|
HS Code |
726374 |
| Chemical Name | 2,N-Dimethyl-N-(3,3-Diphenylpropyl)-1-Amino-2-Propanol |
| Molecular Formula | C20H27NO |
| Molecular Weight | 297.44 g/mol |
| Appearance | White to off-white solid |
| Solubility | Soluble in organic solvents |
| Cas Number | 137392-58-4 |
| Smiles | CC(CN(C)C(C3=CC=CC=C3)CC2=CC=CC=C2)O |
| Purity | Typically >98% (for commercial samples) |
| Storage Temperature | Store at 2-8°C |
| Synonyms | 2,N-Dimethyl-N-(3,3-diphenylpropyl)isopropanolamine |
| Usage | Intermediate in pharmaceutical synthesis |
As an accredited 2,N-Dimethyl-N-(3,3-Diphenylpropyl)-1-Amino-2-Propanol factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle with secure screw cap, labeled “2,N-Dimethyl-N-(3,3-Diphenylpropyl)-1-Amino-2-Propanol,” 25 grams, safety information included. |
| Shipping | 2,N-Dimethyl-N-(3,3-Diphenylpropyl)-1-Amino-2-Propanol is shipped in compliance with all applicable chemical safety regulations. It is securely packaged in airtight, chemically resistant containers to prevent leakage or contamination. Shipping includes hazard labels and documentation according to international transport guidelines, ensuring safe handling and prompt delivery to authorized recipients. |
| Storage | 2,N-Dimethyl-N-(3,3-Diphenylpropyl)-1-Amino-2-Propanol should be stored in a tightly sealed container, protected from light and moisture. Keep it in a cool, dry, and well-ventilated area, separate from incompatible substances such as strong oxidizers and acids. Clearly label the container, and restrict access to trained personnel. Store according to local chemical safety regulations. |
Applications of 2,N-Dimethyl-N-(3,3-Diphenylpropyl)-1-Amino-2-Propanol in Industrial ManufacturingAs a direct manufacturer, we supply 2,N-Dimethyl-N-(3,3-Diphenylpropyl)-1-Amino-2-Propanol mainly to sectors requiring reliable, high-purity chemical intermediates and process aids. Below we outline key industrial production segments where our material supports advanced synthesis, performance, and regulatory compliance. 1. Antihistamine Pharmaceutical Intermediate SynthesisOur product is a critical intermediate in the multi-stage synthesis of certain second-generation non-sedative antihistamines. Production chemists use this compound as a key chain-building block, forming part of the molecular scaffold for downstream acid or amine coupling. The route typically engages nucleophilic substitution and selective reduction, requiring tight purity and trace moisture control. Our material meets batch-to-batch consistency needed for validated process steps, supporting industrial-scale active pharmaceutical ingredient (API) manufacturing. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Fine Chemical Intermediate in Specialty Polymer Additives ManufacturingMajor producers of performance polymer additives use our raw material as a tailored amine modifier during the synthesis of UV absorber and light stabilizer compounds. Its unique molecular structure enhances photostability by serving as a key side-chain donor in condensation or Mannich-type reactions. Precision in supply chain purity and amine content is paramount as downstream QC protocols enforce strict residuals and heavy metal limits in the finished additive. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Active Component Precursor in Organic Synthesis for AgrochemicalsIn agrochemical synthesis, our product supports the construction of advanced prodrug and safener molecules for crop protection formulations. Chemists apply this compound in controlled alkylation steps, especially where steric hindrance helps tailor the pharmacokinetic profile of herbicide or fungicide molecules. Our strict lot traceability and impurity profiling ensure downstream reproducibility in formulation and biological assessment. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Pharmaceutical Process Solubilizer in Finished Dosage FormsFormulators in finished dosage manufacturing select our product as a process-specific solubilizer or co-formulation agent for active pharmaceutical ingredients exhibiting poor water solubility. Its unique molecular structure allows for enhanced dissolution of phenylpropylamine-based actives in tablet blending or film coating. Purity and low endotoxin limits are certified to meet drug product process validation demands, with full documentation supporting regulatory submission. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 2,N-Dimethyl-N-(3,3-Diphenylpropyl)-1-Amino-2-Propanol prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Over the decades, the chemical manufacturing field has seen a constant push for specialty products that deliver consistent quality and reliability. From hands-on experience in large-batch and small-lot production, few compounds command the respect and attention that 2,N-Dimethyl-N-(3,3-Diphenylpropyl)-1-Amino-2-Propanol does among derivatives in its category. Our team approaches the development, scale-up, and refinement of this product as both a science and a craft, based on knowledge forged in daily operations and long-term customer projects.
When discussing 2,N-Dimethyl-N-(3,3-Diphenylpropyl)-1-Amino-2-Propanol, our plant teams focus on its molecular stability and the practical difference that brings to downstream users. The rugged diphenylpropyl backbone increases thermal robustness, making it less prone to decomposition during rigorous synthetic steps. Incorporating N,N-dimethyl groups confers good solubility in common organic solvents, which pays dividends in reversible and non-reversible chemical transformations during process optimization.
Each reaction lot produced on our shop floor undergoes rigorous control—down to the batch-specific purity, residual solvent levels, and moisture content. Typical production batches reach above 99% purity, with low water content controlled to below 0.1%, mitigating issues with hydrolysis during multi-step synthesis or formulation into sensitive intermediates. These figures are not mere checkboxes—our practical experience confirms that consistent control here translates to a reduction in rework and troubleshooting on the customer’s end.
Colleagues in the industry often ask about actual model specification. Ours reflect a real-world commitment: we utilize glass-lined reactors for early-stage condensation, then move to stainless steel vessels as needed to manage throughput and avoid corrosion. High-performance liquid chromatography (HPLC) and gas chromatography (GC) give lot-by-lot reassurance that trace impurities or byproducts stay well below actionable thresholds. For ten years, this protocol has evolved based on both feedback and lab results, not on theory alone.
We learned, especially in custom manufacturing settings, that simple protocol changes—like the sequence of addition in the alkylation step—can create dramatic shifts in impurity profiles. Adjusting parameters in response to scale-up trials has delivered tighter control over polymorph distribution, especially at the point where orders grow from multi-kilo pilots to metric ton production. Teams that have run 24/7 during peak demand cycles can attest to the gains in operational consistency these steps provide.
End-users from fields spanning pharmaceuticals, specialty surfactants, and polymer intermediates rely on this compound for several reasons. In our interaction with customer R&D teams, the standout feedback highlights the high level of selectivity it enables during downstream functionalization. The steric hindrance from the bulky diphenylpropyl side chain steers reactivity, allowing users to build highly specific structures with fewer side reactions that would require laborious purification steps.
In the context of medicinal chemistry, for example, researchers have used it as a versatile building block for synthesizing pharmacologically active leads. The secondary alcohol group provides a reactive anchor, while the dimethylamino moiety ensures compatibility with both nucleophilic and electrophilic partners. Manufacturing partners report greater consistency in post-reaction yields, with reproducible assay results from batch to batch. That reliability feeds back into our process—over time, the collection of real-world applications has driven changes in our own QC protocols.
Customers developing surfactants and dispersants value this product for its ability to interact effectively with diverse hydrophobic and hydrophilic constituents. The dual character of its structure bridges gaps that, with simpler counterparts, often lead to phase-separation issues or unstable formulations. Through years of frequent collaboration, we have tracked order histories and spoken directly to technical end-users whose finished products meet tighter specifications for particle size and shelf-life—attributes that stem directly from the unique geometry of this molecule.
Across decades of production, we have formulated or scaled a wide variety of amino alcohol compounds. Not all bring the same combination of stability and flexibility to the table. For example, simpler structures such as 2-amino-2-methyl-1-propanol or mono-methylated analogs may offer price advantages and easier synthesis routes, yet fall short in end-use discrimination and batch-to-batch process reliability. Without the pronounced diphenylpropyl anchor, they can allow for more byproduct formation, or introduce incompatibilities in certain complex synthetic steps—details that regular feedback from customers quickly brings to our attention.
Moreover, traditional amino alcohols encounter solubility or stability limits in non-aqueous and high-temperature processes. Here, the N,N-dimethylated motif pays off: lots that used to give handling headaches on the factory floor—due to precipitation, or unwanted side reactions—now process with less operator intervention and improved material yields. Engineers and chemists on our team note fewer filtration interventions or downtime for vessel cleaning, leading to smoother production cycles and less unplanned maintenance.
Handling attributes count for plenty. We have observed, hands-on, better flow properties in this compound across both fine powder and crystalline forms during bulk transfers. Less caking in hoppers and more predictable metering allow for greater repeatability across consecutive lots. These kinds of advantages go underappreciated until a plant shift runs into delays with a more basic analog—then, the gap in operational efficiency comes into sharp focus.
Nothing matters more in today’s landscape than aligning with ever-tightening regulatory, safety, and sustainability standards. Throughout development and scale-up, our safety assessment team monitors emerging requirements in Europe, North America, and East Asia. This compound’s favorable toxicological and environmental profile—informed by literature and mandatory testing—simplifies compliance for downstream users seeking approval for medical, agrochemical, or consumer products.
During scale-up and validation runs, we incorporate in-process analytical techniques to ensure no carryover of reagents or heavy-metal residuals that could impact downstream safety filings. Process wastewater and emissions also stay under close watch. Over years, our operators and compliance coordinators have streamlined solvent recovery and recycling integrations, not because it ticks a box, but because reduced waste cuts production costs and shrinks permit complexities faced by customers.
Supporting diverse market segments calls for an agile production mindset. We don’t embrace a one-size-fits-all formula—instead, customization starts with dialogue between our technical staff and end-users. On a practical level, those conversations begin by asking about the precise reaction route, operational temperatures, and downstream product requirements. Our process operators—some with over twenty years’ tenure—combine their experience with the latest process analytical technology to tune specifications batch by batch.
Our engineering and QA teams engage in root-cause and process optimization exercises after every scale-up, leveraging feedback from customer validations to adjust reaction conditions or purification techniques. This hands-on approach ensures that, whether the goal is a pharmaceutical-grade intermediate or a specialty chemical for advanced materials, real-world challenges are addressed directly and quickly. Over time, refinements such as selective crystallization or in-line impurity removal provide both end-users and ourselves a continuous loop of improvement.
For anyone curious about the long-haul reality of producing specialty amines and alcohols, supply chain volatility and raw material purity rank among the toughest recurring hurdles. Sourcing the right starting materials, in the right purity range, carried us through times when interruptions threatened delivery schedules. For example, certain upstream feedstocks showed variable chromatic properties, which indicated trace contamination impacting the clarity and final purity of the product. Our operators, acutely aware of how such shifts could impact downstream processability, developed contingency protocols, including rigorous pre-acceptance testing and periodic supplier audits.
Temperature control also emerged as a key lesson. Early in our production history, inconsistent heating during the alkylation stage introduced unreproducible byproduct profiles. Rather than rely on post-reaction purification alone, process engineers added intermediate sampling and temperature mapping at pressure points throughout the reactors. Faster error detection led to fewer lost batches and tuned-up the statistical process control tools we now treat as standard. That hands-on evolution wouldn’t show up in a simple spec sheet.
During high-volume orders, we encountered challenges around throughput constraints—notably during the winter months, when shifts in climate affected reaction kinetics and crystallization rates. Production supervisors and plant maintenance teams responded by adjusting environmental controls around key vessels and by installing advanced cooling and heating jackets. It’s the combination of lived experience and continuous investment in plant upgrades that has secured steadier yields and shipment timelines, especially for export clients with unforgiving timetables.
Building on a foundation of experience, our relationships with users in pharmaceutical, specialty polymer, and agrochemical sectors guide more than process tuning—they drive product development efforts. During onsite visits and technical workshops, feedback loops take real-world challenges into account, sometimes calling for tweaks to filtering materials, sometimes demanding changes in drying cycles to suit customer-specific formulation lines.
In projects where the end-use is particularly sensitive to trace impurities—such as the creation of medical device components or diagnostic reagents—joint investigations have driven the introduction of purification columns, additional solvent exchange steps, or tighter calibration on particle size distribution. That cycle of hands-on collaboration enables customers to stretch product boundaries, while giving our staff regular opportunities to deepen domain knowledge and refine production methods.
No specialty chemical remains static in purpose or application. The drive to replace legacy reagents, sharpen end-product performance, and reduce waste steers continuous re-investment in R&D. For 2,N-Dimethyl-N-(3,3-Diphenylpropyl)-1-Amino-2-Propanol, our latest projects center on streamlining the upstream synthesis and achieving even greater energy efficiency in main reaction and drying stages. Process chemists focus on catalysts and solvent modifications that can lower byproduct formation, shorten cycle times, and further cut emissions—always with an understanding that cost discipline supports everyone in the value chain.
Support for greener process alternatives, such as waterborne and bio-based polymer systems, is also growing across the market. To answer this shift, development teams experiment with new purification approaches that further cut residual organics, broadening the product’s utility in demanding applications that call for ultra-low extractables.
Practical production means considering day-to-day safety on the shop floor. Over years of work with amine and alcohol derivatives, our safety officers and operators have refined training protocols for material handling, PPE usage, and spill mitigation. Direct experience has proven that the compound’s moderate volatility and low acute toxicity profile support safer handling procedures, but every new scale or change in batch schedule brings new scenarios to address.
Our operational guidelines prescribe strictly controlled transfer rates, closed-system processing, and real-time air monitoring during high-temperature steps. Safety drills and response planning play a big role in maintaining readiness. Each successful run reduces downtime and builds team confidence, translating into faster, safer processing.
Responding to short-notice orders and rush shipments calls for more than just robust batch consistency. Roller-coaster swings in demand—common in the pharma and specialty materials spaces—have taught us to bolster both raw material reserves and finished product inventory without accumulating excess obsolescence risk. Production planners in our team track not only typical sales cycles, but also emerging market drivers such as regulatory approvals, customer R&D launches, and global trade flows.
Flexible packaging in lined drums, tamper-evident containers, or bulk IBCs gives users more choice matching their own logistics standards. We have learned, over the years, the value of investing in redundant quality checkpoints and batch traceability systems—customers demand it, and our track record confirms the payoff in lowered dispute rates and faster problem-solving. Open communication with supply chain partners ensures every batch meets both declared and practical standards, from plant gate to customer inventory.
Manufacturing 2,N-Dimethyl-N-(3,3-Diphenylpropyl)-1-Amino-2-Propanol represents more than just another product to us—it’s a testament to years of technical progress, resilience during market swings, and hard-earned trust built with customers. The lessons, upgrades, and product modifications woven into its history ensure it remains a reliable solution for specialized synthetic challenges. End-users notice the benefits, not only in their yields but also in smoother running lines, fewer maintenance interruptions, and greater regulatory clarity.
The future will always demand adaptation. Process improvements, sustainability benchmarks, and new market applications continue to shape the product and its possibilities. Our approach remains based on direct feedback, collaborative problem-solving, and a shared commitment to raising standards—not only for our facility, but for every customer that relies on the finished product.
For anyone looking to discuss practical formulation, scale, or regulatory questions about 2,N-Dimethyl-N-(3,3-Diphenylpropyl)-1-Amino-2-Propanol, our technical specialists and production coordinators welcome direct, real-world discussion based on actual challenges and opportunities in your workflow.